Health Trials

Bupivacaine Liposome Versus Bupivacaine for Ultrasound-Guided Suprascapular Nerve Combined With Axillary Nerve Block in Analgesia After Arthroscopic Shoulder Surgery

ConditionsArthroscopic Shoulder SurgeryUltrasound Guided Nerve BlockBupivacaineSuprascapular Nerve BlockAxillary Nerve Block
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorHuazhong University of Science and Technology

About this trial

This trial is designed to compare the post-operative analgesic efficacy and safety of liposomal bupivacaine versus plain bupivacaine when both are used for ultrasound-guided combined suprascapular and axillary nerve block in patients undergoing elective arthroscopic shoulder surgery.

Eligibility criteria

Qualifiers

Aged 18-60 years

ASA physical status I-II

Undergoing unilateral arthroscopic shoulder surgery

The Operative time between 1and 4 hours

Disqualifiers

Anticipated operative time < 1 h or > 4 h

Severe cardiopulmonary insufficiency

Hepatic or renal dysfunction

Coagulopathy

Trial design

Treatments tested in this trial

  • Group A（ liposomal bupivacene）
  • Group B（bupivacene）

Treatment groups

60 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Huazhong University of Science and Technology

Lead sponsor

Source ClinicalTrials.gov